PL2662448T3 - Kierowana do kości fosfataza alkaliczna, zestawy i sposoby jej zastosowania - Google Patents
Kierowana do kości fosfataza alkaliczna, zestawy i sposoby jej zastosowaniaInfo
- Publication number
- PL2662448T3 PL2662448T3 PL13002327T PL13002327T PL2662448T3 PL 2662448 T3 PL2662448 T3 PL 2662448T3 PL 13002327 T PL13002327 T PL 13002327T PL 13002327 T PL13002327 T PL 13002327T PL 2662448 T3 PL2662448 T3 PL 2662448T3
- Authority
- PL
- Poland
- Prior art keywords
- amino acid
- alkaline phosphatase
- kits
- methods
- bones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03001—Alkaline phosphatase (3.1.3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/025—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a parvovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cereal-Derived Products (AREA)
- Adornments (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91758907P | 2007-05-11 | 2007-05-11 | |
| EP13002327.8A EP2662448B1 (en) | 2007-05-11 | 2008-05-12 | Bone targeted alkaline phosphatase, kits and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2662448T3 true PL2662448T3 (pl) | 2017-07-31 |
Family
ID=40001639
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13002327T PL2662448T3 (pl) | 2007-05-11 | 2008-05-12 | Kierowana do kości fosfataza alkaliczna, zestawy i sposoby jej zastosowania |
| PL11004496T PL2368999T3 (pl) | 2007-05-11 | 2008-05-12 | Kierowana do kości fosfataza alkaliczna, zestawy oraz metody wykorzystywania |
| PL08757088T PL2158319T4 (pl) | 2007-05-11 | 2008-05-12 | Fosfataza alkaliczna kierowana do kości, zestawy i zastosowanie |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11004496T PL2368999T3 (pl) | 2007-05-11 | 2008-05-12 | Kierowana do kości fosfataza alkaliczna, zestawy oraz metody wykorzystywania |
| PL08757088T PL2158319T4 (pl) | 2007-05-11 | 2008-05-12 | Fosfataza alkaliczna kierowana do kości, zestawy i zastosowanie |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20100297119A1 (enExample) |
| EP (3) | EP2158319B1 (enExample) |
| JP (1) | JP5732603B2 (enExample) |
| AT (1) | ATE536413T1 (enExample) |
| AU (1) | AU2008250945B2 (enExample) |
| BR (2) | BR122019000505B1 (enExample) |
| CA (1) | CA2687001C (enExample) |
| CY (1) | CY2016005I2 (enExample) |
| DE (1) | DE202008018131U1 (enExample) |
| DK (3) | DK2158319T3 (enExample) |
| ES (3) | ES2380546T3 (enExample) |
| FR (1) | FR16C0007I2 (enExample) |
| HR (1) | HRP20140416T1 (enExample) |
| HU (2) | HUE031655T2 (enExample) |
| IL (1) | IL202057A0 (enExample) |
| LT (1) | LTC2368999I2 (enExample) |
| LU (1) | LU92976I2 (enExample) |
| ME (1) | ME01828B (enExample) |
| NL (1) | NL300798I1 (enExample) |
| NO (1) | NO2016002I1 (enExample) |
| PL (3) | PL2662448T3 (enExample) |
| PT (3) | PT2662448T (enExample) |
| RS (1) | RS53302B (enExample) |
| SI (2) | SI2662448T1 (enExample) |
| WO (1) | WO2008138131A1 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2348114T3 (pl) | 2004-04-21 | 2019-08-30 | Alexion Pharmaceuticals, Inc. | Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość |
| US20070081984A1 (en) | 2005-10-11 | 2007-04-12 | Shunji Tomatsu | Compositions and methods for treating hypophosphatasia |
| US8784833B2 (en) * | 2006-06-27 | 2014-07-22 | Saint Louis University | Prenatal enzyme replacement therapy for hypophosphatasia |
| WO2008151088A2 (en) | 2007-06-01 | 2008-12-11 | University Of Maryland, Baltimore | Immunoglobulin constant region fc receptor binding agents |
| ES2628841T3 (es) | 2010-03-12 | 2017-08-04 | Alexion Pharmaceuticals, Inc. | Proteínas de fusión npp1 |
| BR112012027765A2 (pt) * | 2010-04-30 | 2019-09-24 | Enobia Pharma Inc | métodos, composições e kits para tratamento de distúrbios de mineralização da matriz. |
| EP2598533B1 (en) | 2010-07-28 | 2019-02-20 | Gliknik Inc. | Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions |
| EP2658979B1 (en) | 2010-12-27 | 2018-02-14 | Alexion Pharmaceuticals, Inc. | Compositions comprising natriuretic peptides and methods of use thereof |
| WO2013058833A1 (en) * | 2011-10-19 | 2013-04-25 | Enobia Canada Limited Partnership | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| KR20150058236A (ko) | 2012-08-20 | 2015-05-28 | 글리크닉 인코포레이티드 | 항원 결합 및 다가 fc 감마 수용체 결합 활성을 가진 분자 |
| CN106164262B (zh) * | 2014-01-24 | 2020-08-07 | 安-法玛公司 | 嵌合型碱性磷酸酶样蛋白 |
| US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
| MX389350B (es) * | 2014-12-05 | 2025-03-19 | Alexion Pharma Inc | Fosfatasas alcalinas recombinantes y usos de las mismas para el tratamiento de convulsiones. |
| US10603361B2 (en) | 2015-01-28 | 2020-03-31 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
| AU2016297862C1 (en) | 2015-07-24 | 2022-12-15 | Gliknik Inc. | Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin Fc compositions with enhanced complement binding |
| KR102644116B1 (ko) * | 2015-08-17 | 2024-03-05 | 알렉시온 파마슈티칼스, 인코포레이티드 | 알칼린 포스파타제의 제조 |
| WO2017058822A1 (en) * | 2015-09-28 | 2017-04-06 | Alexion Pharmaceuticals, Inc. | Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia |
| JP2018533571A (ja) | 2015-10-30 | 2018-11-15 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 患者の頭蓋縫合早期癒合症を治療するための方法 |
| WO2017155569A1 (en) * | 2016-03-08 | 2017-09-14 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in children |
| WO2017171871A1 (en) * | 2016-04-01 | 2017-10-05 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in adolescents and adults |
| CA3019726A1 (en) * | 2016-04-01 | 2017-10-05 | Alexion Pharmaceuticals, Inc. | Treating muscle weakness with alkaline phosphatases |
| EP3436020A4 (en) | 2016-04-01 | 2019-12-25 | Alexion Pharmaceuticals, Inc. | METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS |
| EP3464573A4 (en) | 2016-06-06 | 2020-02-19 | Alexion Pharmaceuticals, Inc. | EFFECTS OF METALS ON THE PRODUCTION OF ALKALINE PHOSPHATASES |
| US11034775B2 (en) | 2016-06-07 | 2021-06-15 | Gliknik Inc. | Cysteine-optimized stradomers |
| ES2887573T3 (es) | 2016-06-27 | 2021-12-23 | Alexion Pharma Inc | Métodos para el tratamiento de la hipofosfatasia en niños y adolescentes |
| WO2018035420A1 (en) | 2016-08-18 | 2018-02-22 | Alexion Pharmaceuticals, Inc. | Methods for treating tracheobronchomalacia |
| AU2017367699B2 (en) * | 2016-11-30 | 2023-12-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| KR20190093186A (ko) | 2016-12-09 | 2019-08-08 | 글리크닉 인코포레이티드 | 다가 Fc 화합물에 의해 염증성 장애를 치료하는 방법 |
| PE20191354A1 (es) | 2016-12-09 | 2019-10-01 | Gliknik Inc | Optimizacion de fabricacion de gl-2045, un stradomer multimerizante |
| JP7142021B2 (ja) * | 2017-03-09 | 2022-09-26 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 糖タンパク質製造プロセス |
| JP2020512363A (ja) * | 2017-03-31 | 2020-04-23 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 成人及び青年における低ホスファターゼ症（ｈｐｐ）を治療する方法 |
| WO2019067502A1 (en) | 2017-09-27 | 2019-04-04 | Alexion Pharmaceuticals, Inc. | METHODS FOR IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING RECOMBINANT ECTO-NUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE |
| EP3737750B1 (en) | 2018-01-09 | 2024-06-05 | Theriva Biologics, Inc. | Alkaline phosphatase agents for treatment of neurodevelopmental disorders |
| JP7214962B2 (ja) * | 2018-01-17 | 2023-01-31 | 東ソー株式会社 | アルカリホスファターゼ高発現動物細胞 |
| WO2019183209A1 (en) | 2018-03-20 | 2019-09-26 | Synthetic Biologics, Inc. | Alkaline phosphatase agents for treatment of radiation disorders |
| US11638699B2 (en) | 2018-03-20 | 2023-05-02 | Theriva Biologics, Inc. | Intestinal alkaline phosphatase formulations |
| US11913039B2 (en) | 2018-03-30 | 2024-02-27 | Alexion Pharmaceuticals, Inc. | Method for producing recombinant alkaline phosphatase |
| CN110499284A (zh) * | 2018-05-17 | 2019-11-26 | 西安组织工程与再生医学研究所 | Wnt信号通路激活剂在制备治疗基因ALPL敲除小鼠牙硬组织矿化异常产品中的应用 |
| WO2019232283A1 (en) | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| US12268733B2 (en) | 2018-08-10 | 2025-04-08 | Alexion Pharmaceuticals, Inc. | Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase |
| KR20220005560A (ko) | 2019-05-06 | 2022-01-13 | 신세틱 바이오로직스, 인코퍼레이티드 | 알칼리성 포스페이트-기반 종양학 치료제 |
| JP2023504208A (ja) * | 2019-12-09 | 2023-02-01 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | アルカリホスファターゼポリペプチド及びその使用方法 |
| US12478662B2 (en) | 2020-01-03 | 2025-11-25 | The United States of America as represented by the Secretary Department of Heath and Human Services | TNAP locally administered for promoting periodontal health |
| CA3190513A1 (en) * | 2020-09-03 | 2022-03-10 | Jeffrey S. Bartlett | Soluble alkaline phosphatase constructs and expression vectors including a polynucleotide encoding for soluble alkaline phosphatase constructs |
| KR102571967B1 (ko) * | 2021-01-21 | 2023-08-30 | 주식회사 마라나노텍코리아 | Alp 측정용 바이오 센서 |
| US12083169B2 (en) * | 2021-02-12 | 2024-09-10 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
| CA3263089A1 (en) * | 2022-08-31 | 2024-03-07 | University Of Utah Research Foundation | GJA1-20K COMPOSITIONS AND METHODS FOR MITIGATING ISCHEMIC-REPERFUSION INJURY |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7008A (en) * | 1850-01-08 | Improvement in alloys for points of lightning-rods | ||
| JP3532566B2 (ja) | 1993-06-24 | 2004-05-31 | エル． グラハム，フランク | 遺伝子治療のためのアデノウイルスベクター |
| DE69435223D1 (de) | 1993-10-25 | 2009-09-03 | Canji Inc | Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung |
| US7252989B1 (en) | 1994-04-04 | 2007-08-07 | Board Of Regents, The University Of Texas System | Adenovirus supervector system |
| WO2001036620A2 (en) | 1999-11-16 | 2001-05-25 | Genzyme Corporation | Vectors and transgenies with regulatory elements for gene delivery to the liver |
| DE60233047D1 (de) | 2001-05-14 | 2009-09-03 | Gbp Ip Llc | Lentivirale vektoren kodierend für gerinnungsfaktoren für die gentherapie |
| CA2433479A1 (en) | 2002-07-22 | 2004-01-22 | F. Hoffmann-La Roche Ag | Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof |
| PL2348114T3 (pl) * | 2004-04-21 | 2019-08-30 | Alexion Pharmaceuticals, Inc. | Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość |
| US20070081984A1 (en) | 2005-10-11 | 2007-04-12 | Shunji Tomatsu | Compositions and methods for treating hypophosphatasia |
| MXPA06014972A (es) | 2004-06-23 | 2007-03-07 | Genzyme Corp | Metodos y composiciones para el tratamiento de enfermedades poliquisticas. |
| US20090142347A1 (en) * | 2004-09-29 | 2009-06-04 | The Burnham Institute For Medical Research | Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification |
| JP2008521575A (ja) | 2004-12-01 | 2008-06-26 | ジェンザイム・コーポレイション | 肝臓を標的とした遺伝物質の送達方法 |
-
2008
- 2008-05-12 PT PT130023278T patent/PT2662448T/pt unknown
- 2008-05-12 AT AT08757088T patent/ATE536413T1/de active
- 2008-05-12 WO PCT/CA2008/000923 patent/WO2008138131A1/en not_active Ceased
- 2008-05-12 DE DE202008018131U patent/DE202008018131U1/de not_active Expired - Lifetime
- 2008-05-12 PT PT08757088T patent/PT2158319E/pt unknown
- 2008-05-12 DK DK08757088.3T patent/DK2158319T3/da active
- 2008-05-12 PL PL13002327T patent/PL2662448T3/pl unknown
- 2008-05-12 EP EP08757088A patent/EP2158319B1/en active Active
- 2008-05-12 ME MEP-2014-48A patent/ME01828B/me unknown
- 2008-05-12 ES ES08757088T patent/ES2380546T3/es active Active
- 2008-05-12 US US12/599,679 patent/US20100297119A1/en not_active Abandoned
- 2008-05-12 JP JP2010507770A patent/JP5732603B2/ja active Active
- 2008-05-12 BR BR122019000505-2A patent/BR122019000505B1/pt active Search and Examination
- 2008-05-12 DK DK13002327.8T patent/DK2662448T3/en active
- 2008-05-12 CA CA2687001A patent/CA2687001C/en active Active
- 2008-05-12 EP EP11004496.3A patent/EP2368999B1/en active Active
- 2008-05-12 AU AU2008250945A patent/AU2008250945B2/en active Active
- 2008-05-12 RS RS20140237A patent/RS53302B/sr unknown
- 2008-05-12 DK DK11004496.3T patent/DK2368999T3/da active
- 2008-05-12 PL PL11004496T patent/PL2368999T3/pl unknown
- 2008-05-12 EP EP13002327.8A patent/EP2662448B1/en active Active
- 2008-05-12 ES ES13002327T patent/ES2619332T3/es active Active
- 2008-05-12 SI SI200831780A patent/SI2662448T1/sl unknown
- 2008-05-12 BR BRPI0811198A patent/BRPI0811198B8/pt active IP Right Grant
- 2008-05-12 ES ES11004496.3T patent/ES2471915T3/es active Active
- 2008-05-12 SI SI200831200T patent/SI2368999T1/sl unknown
- 2008-05-12 PL PL08757088T patent/PL2158319T4/pl unknown
- 2008-05-12 HU HUE13002327A patent/HUE031655T2/hu unknown
- 2008-05-12 PT PT110044963T patent/PT2368999E/pt unknown
-
2009
- 2009-11-11 IL IL202057A patent/IL202057A0/en unknown
-
2014
- 2014-05-08 HR HRP20140416AT patent/HRP20140416T1/hr unknown
-
2016
- 2016-01-15 HU HUS1600005C patent/HUS1600005I1/hu unknown
- 2016-01-28 LT LTPA2016004C patent/LTC2368999I2/lt unknown
- 2016-02-02 NO NO2016002C patent/NO2016002I1/no not_active IP Right Cessation
- 2016-02-10 LU LU92976C patent/LU92976I2/xx unknown
- 2016-02-19 FR FR16C0007C patent/FR16C0007I2/fr active Active
- 2016-02-23 CY CY2016005C patent/CY2016005I2/el unknown
- 2016-02-26 NL NL300798C patent/NL300798I1/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2662448T3 (pl) | Kierowana do kości fosfataza alkaliczna, zestawy i sposoby jej zastosowania | |
| BRPI0414593A (pt) | derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1 | |
| BRPI0411528A (pt) | uso de isomalte como prebiótico | |
| MEP59208A (en) | Activin-actriia antagonists and uses for promoting bone growth | |
| EP1473331A4 (en) | ANTIFOULING COATING COMPOSITION | |
| ATE542803T1 (de) | Verfahren zur herstellung von dihydrochinazolinen | |
| CY1108321T1 (el) | Καινοφανη παραγωγα δικαρβοξυλικου οξεος | |
| CR8312A (es) | Nuevas sulfonamidas como agentes fitosanitarios | |
| CR10303A (es) | "derivados de quinolina y su uso com pesticidas" | |
| EA200970192A1 (ru) | Производные 5,6-бисарил-2-пиридин-карбоксамида, их получение и их применение в терапии в качестве антагонистов рецепторов уротензина ii | |
| EA200700702A1 (ru) | Аналоги локсапина и способы их применения | |
| BR0300119A (pt) | Composição aquosa, e, estrutura compósita | |
| CO6501122A2 (es) | Nuevos derivados de (heterociclo-piperidina condensada) - (piperazinil)-1-alcanona o de (heterocilco-pirrolidina condensada)-(pieprazinil)-1-alcanona y su utilizacion como inhibidores de p75 | |
| AR027575A1 (es) | Benzoilciclohexenonas substituidas | |
| DE502006007113D1 (de) | Aminosäuresalze von rosiglitazon | |
| EA200601743A1 (ru) | Выделенный полипептид реналазы и его применение | |
| DK2084198T3 (da) | Beklædningssammensætning | |
| CR9529A (es) | Anilidas de acido tiazolcarboxilico | |
| ITMI20031790A1 (it) | Antagonistici abiotici dell'eparina. | |
| CY1115263T1 (el) | Αλκαλικη φωσφαταση στοχευμενη στα οστα, κιτ και μεθοδοι χρησης αυτων | |
| RU2008115714A (ru) | Ингибитор 8-оксогуанин-днк-гликозилазы человека | |
| EA200702258A1 (ru) | Производные 2-(1н-индолилсульфанил)бензиламина в качестве ssri |